STRICYTE 200 MG INJECTION 1 is used as chemotherapy in adults for ovarian cancer (recurrent after platinum-based therapy), metastatic breast cancer, non-small cell lung cancer, pancreatic cancer and bladder cancer, usually in combination with other chemotherapy medicines.
It contains gemcitabine (200 mg), a cytotoxic antimetabolite. It is given by a healthcare professional only.
All monitoring and care during treatment, including blood counts and kidney and liver function tests, are managed by the healthcare team.
Tell your doctor about any kidney or liver problems before treatment, and about all medicines being taken. Report fever, chills or any sign of infection between cycles without delay.































